Emily Poe

Global Practice Leader, Healthcare Communications

Emily Poe brings nearly two decades of healthcare and scientific communications to the W2O Group.  Her expertise spans U.S., global, corporate and product communications that help clients achieve their business objectives. In her role, she teams with senior leaders on strategy creation and operational excellence across W2O’s healthcare clients.

Committed to excellence in client service, her current and former clients have included Pfizer, Merck, Bayer, Bristol-Myers-Squibb, Janssen, EMD Serono, Boston Scientific, Onyx Pharmaceuticals (now a part of Amgen Inc.) and Myriad Genetics, as well as platform companies such as Sony Medical Systems, Applied Biosystems and Sequenom, Inc. and third-party organizations such as the National Headache Foundation.

Prior her position at W2O Group, Emily was Executive Vice President for the Healthcare practice at Cohn & Wolfe, where she oversaw communications for global and U.S. franchises, as well as other scientifically focused programming. She has also held leadership positions at Euro RSCG Life PR and Noonan Russo Communications.

Emily began her career as an Assistant Editor at Nature Publishing Group.  She has a degree in Biological Sciences from Cornell University, where she published a paper on genetic implications of insect neurobehavior in the journal Nature.